Head and Neck Cancer Diagnostics Market - Growth, Trends, and Forecast (2020 - 2025)

The market is segmented by Diagnostic Method (Diagnostic Imaging Equipment, Endoscopy Screening Equipment, Bioscopy Screening Tests, Dental Diagnostic Methods, Other Diagnostic Methods), End-User and Geography

Market Snapshot

Study Period:

2017-2025

Base Year:

2019

Fastest Growing Market:

Asia Pacific

Largest Market:

North America

CAGR:

9.5 %

Major Players:

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Market Overview

The head and neck cancer diagnostics market is expected to grow at a high rate. Some of the major trends driving the market are the increasing number of cases of target diseases, growing aging population that increased the prevalence of chronic diseases, increasing number of diagnostic procedures for head and neck cancer, and better healthcare initiatives by governments and various private organizations.

The increasing disposable incomes that lead to rise in the healthcare expenditure of people, rising demand for diagnostic imaging, advances in treatment modes, and incorporation of novel technologies in diagnostic equipment will further propel market growth during the forecast period.

Some of the restraining factors for this market includes the low adoption rate of digital technology-based systems, conventional CT and MRI scanners, excise duty imposed on sale of medical devices in mature markets, lack of trained professionals for operating the instruments, high cost associated with the treatment modes and lack of awareness among the people.

Scope of the Report

Head and neck cancer is a group of cancers that usually originate in the squamous cells that line the mouth, nose and throat. The typical symptoms include a persistent sore throat, difficulty swallowing, mouth sores that won't heal, a hoarse voice, and persistent swelling of the neck from enlarged lymph nodes.

By Diagnostic Method
Diagnostic Imaging Equipment
Endoscopy Screening Equipment
Bioscopy Screening Tests
Dental Diagnostic Methods
Other Diagnostic Methods
By End User
Hospitals
Diagnostic Centers
Other End Users
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Diagnostic Imaging Equipment is Expected to Dominate the Market

Medical imaging is the technique and process of creating visual representations of the interior of a body for clinical analysis and medical intervention, as well as visual representation of the function of some organs or tissues (physiology). Head and neck cancer is a group of cancers that usually originate in the squamous cells that line the mouth, nose and throat. To confirm a diagnosis of cancer and determine if it has spread, head MRI, CT of the sinuses, head CT, panoramic dental x-ray, dental cone beam CT, PET/CT or chest imaging are some of the most common procedures.

Moreover, as per Gunnar Juliusson et al. report published in Acta Radiologica Open Journal 2019, the number of CT examinations per 1000 patients has increased from 51 in 2007 to 108 in 2017 in Europe. However this indicates that the more CT scans are being adopted and hence this is expected to positively impact the diagnostic imaging equipment market as well.

To understand key trends, Download Sample Report

North America is Expected to Dominate the Head and Neck Cancer Diagnostics Market

According to the National Health Institute, the head and neck cancer accounts for approximately 4% of all cancers in the United States. This type of cancer is found to be more than twice as common among men as they are among women. The researchers also estimated that more than 65,000 men and women in the country have been diagnosed with head and neck cancer in 2017. Thus, this huge disease burden will help in the growth of the market.

The Epidemiology and End Results (SEER) Program estimated that 53,000 new cases of oral cavity and pharyngeal cancer occur in the United States in 2019, making up 3% of all new US cancer cases. The SEER Program also estimated that such cancer cases would account for 10,860 US deaths in the year, making up 1.8% of all cancer deaths. Thus, the growth in these programs has helped in the overall growth of the market. In addition, with the rise in the head and neck cancer in the United States, there is an increased demand for diagnostic imaging and new advancements and innovations are seen in the treatment models, which help in the growth of the overall market.

Hence, the increasing geriatric population worldwide, combined with government and private body initiatives are some of the other factors contributing to the growth of the market.

To understand geography trends, Download Sample Report.

Competitive Landscape

Majority of the head and neck cancer diagnostics equipment are being manufactured by the global key players. Market leaders with more funds for research and better distribution system have established their position in the market. Moreover, Asia-pacific is witnessing an emergence of some small players due to the rise of awareness. This has also helped the market grow.

Table Of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Rise in Incidences of Target Diseases

      2. 4.2.2 Rise in Global Geriatric Population Levels

      3. 4.2.3 Increasing Number of Diagnostic Procedures for Head and Neck Cancer

    3. 4.3 Market Restraints

      1. 4.3.1 High Cost of the Devices and Unfavourable Reimbursement Scenarios

      2. 4.3.2 Dearth of Trained Professionals

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Diagnostic Method

      1. 5.1.1 Diagnostic Imaging Equipment

      2. 5.1.2 Endoscopy Screening Equipment

      3. 5.1.3 Bioscopy Screening Tests

      4. 5.1.4 Dental Diagnostic Methods

      5. 5.1.5 Other Diagnostic Methods

    2. 5.2 By End User

      1. 5.2.1 Hospitals

      2. 5.2.2 Diagnostic Centers

      3. 5.2.3 Other End Users

    3. 5.3 Geography

      1. 5.3.1 North America

        1. 5.3.1.1 United States

        2. 5.3.1.2 Canada

        3. 5.3.1.3 Mexico

      2. 5.3.2 Europe

        1. 5.3.2.1 Germany

        2. 5.3.2.2 United Kingdom

        3. 5.3.2.3 France

        4. 5.3.2.4 Italy

        5. 5.3.2.5 Spain

        6. 5.3.2.6 Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. 5.3.3.1 China

        2. 5.3.3.2 Japan

        3. 5.3.3.3 India

        4. 5.3.3.4 Australia

        5. 5.3.3.5 South Korea

        6. 5.3.3.6 Rest of Asia-Pacific

      4. 5.3.4 Middle-East and Africa

        1. 5.3.4.1 GCC

        2. 5.3.4.2 South Africa

        3. 5.3.4.3 Rest of Middle East and Africa

      5. 5.3.5 South America

        1. 5.3.5.1 Brazil

        2. 5.3.5.2 Argentina

        3. 5.3.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Addent Inc

      2. 6.1.2 GE Healthcare

      3. 6.1.3 Identafi

      4. 6.1.4 Philips Healthcare

      5. 6.1.5 Shimadzu Corporation

      6. 6.1.6 Siemens Healthineers

      7. 6.1.7 Varian Medical Systems

      8. 6.1.8 Apteryx Imaging Inc

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

Related Reports